Skip to main content
Equibles

IRLAB-A · IRLAB Therapeutics AB · Investor Relations

Use IRLAB-A with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IRLAB-A.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1.8040 SEK -0.0160 (-0.88%) At close · Oct 7
Rebalance outlook locked
Market Cap
268.28M SEK
Shares
148.71M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-13 00:00 UTC Interim report January - September 2026 Results publication
2027-02-24 00:00 UTC Year-end report 2026 Results publication

Past events

Date Event Type
2026-06-18 CEO interview with Kristina Torfgård and CFO Gustaf Albèrt at Redeye Event
2026-06-18 Interview with CEO Kristina Torfgård and CFO Gustaf Albèrt at Redeye. Event
2026-06-09 Kristina Torfgård, CEO and Gustaf Albèrt, CFO present at Aktiesdagarna Event
2026-05-08 Interview with CEO Kristina Torfgård and CFO Gustaf Albèrt at Redeye. Event
2026-04-14 Kristina Torfgård, CEO, presents at Redeye Healthcare Day 2026 Event
2026-03-03 Gustaf Albèrt, CFO, presents at Life Science-dagen 2026 Event
2025-12-03 Q&A session with Kristina Torfgård, CEO and Nicholas Waters, EVP, Head of R&D, at Redeye Technology & Life Science Day Event
2025-10-15 Presentation by Kristina Torfgård, CEO, at Redeye’s Theme Event Neurology Presentation
2025-06-10 Presentation by Kristina Torfgård, CEO, at Aktiespararna Presentation
2025-04-10 Presentation by Viktor Siewertz, CFO at Redeye Investor Forum Presentation
2025-04-08 Kristina Torfgård, CEO, presents IRLAB at Redeye Theme: Alzheimer’s & Parkinson’s Event
2025-03-11 Kristina Torfgård, CEO, presents at Stora Aktiedagarna Event
2025-03-05 Viktor Siewertz, CFO, presents at Life Science-dagen 2025 Event
2025-01-30 Viktor Siewertz, CFO, presents at Redeye Investor Forum Event
2024-12-04 Presentation by Kristina Torfgård, CEO, at ABGSC Investor Days Presentation
2024-12-03 Q&A session with Kristina Torfgård, CEO and Nicholas Waters, EVP, Head of R&D, at Redeye Technology & Life Science Day Event
2024-11-19 Kristina Torfgård, CEO, at BioStock Life Science Summit 2024. Event
2024-10-25 Presentation by Kristina Torfgård, CEO, at Redeye’s Theme Event Neurology Presentation
2024-09-16 Q&A with Kristina Torfgård, CEO, at “Investing in Life Science 2024” Event
2024-09-16 Presentation by Kristina Torfgård, CEO, at “Investing in Life Science 2024” Presentation
2024-09-13 CEO interview with Kristina Torfgård at Redeye Event
2024-03-07 Erik Werner presents at Bayes@Lund 2024 Event
2024-03-07 Fireside chat with Viktor Siewertz, CFO, at ABGSC Event
2024-03-06 Viktor Siewertz, CFO, presents at Life Science-dagen Event
2024-03-06 IRLAB to present clinical and preclinical data at the AD/PD™ 2024: 18th International Conference on Alzheimer’s & Parkinson’s Diseases Conference

Source: https://irlab.se/investor-relations/